Found: 12
Select item for more details and to access through your institution.
Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 902, doi. 10.3390/biom13060902
- By:
- Publication type:
- Article
Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1020343
- By:
- Publication type:
- Article
PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis.
- Published in:
- Nature Communications, 2013, v. 4, n. 3, p. 1618, doi. 10.1038/ncomms2604
- By:
- Publication type:
- Article
Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
- Published in:
- Journal of Pathology, 2012, v. 226, n. 4, p. 645, doi. 10.1002/path.3957
- By:
- Publication type:
- Article
Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025547
- By:
- Publication type:
- Article
Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0016984
- By:
- Publication type:
- Article
Transcriptional Repressive H3K9 and H3K27 Methylations Contribute to DNMT1-Mediated DNA Methylation Recovery.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0016702
- By:
- Publication type:
- Article
Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005572
- By:
- Publication type:
- Article
Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2008, v. 3, n. 7, p. 1, doi. 10.1371/journal.pone.0002779
- By:
- Publication type:
- Article
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
- Published in:
- Liver International, 2010, v. 30, n. 1, p. 139, doi. 10.1111/j.1478-3231.2009.02133.x
- By:
- Publication type:
- Article
Regulation of deleted in liver cancer 1 tumor suppressor by protein-protein interactions and phosphorylation.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 2, p. 264, doi. 10.1002/ijc.28505
- By:
- Publication type:
- Article
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1402-x
- By:
- Publication type:
- Article